Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor A, mitochondrial pseudogene 2 (TFAMP2) is a processed pseudogene found in the human genome. It is homologous to the functional mitochondrial transcription factor gene (TFAM), but unlike TFAM, TFAMP2 does not encode a functional protein and does not perform biological roles in mitochondrial transcription or replication. The designation “MTTF1” is commonly used for functional TFAM, so applying it to TFAMP2 may cause confusion; thus, this pseudogene is not considered a valid drug target, nor does it have characterized biological activity or disease associations. Clarifications & Corrections: - The entry TFAMP2 is a pseudogene and not an active protein-coding gene or receptor. - Its aliases overlap with those of the real mitochondrial transcription factor (TFAM), causing ambiguity. In structured databases, MTTF1 usually refers to the active mitochondrial transcription factor, not the pseudogene. - There are multiple TFAM pseudogenes annotated in the human genome, but none of them are established therapeutic targets or have a protein product. - If you seek information on the functional mitochondrial transcription factor A (TFAM/MTTF1), see other entries; otherwise, for TFAMP2, it is correct to flag as a pseudogene entry. In summary: TFAMP2 (Transcription factor A, mitochondrial pseudogene 2) is a non-functional pseudogene, not a therapeutic target, and is often misidentified as MTTF1 (which refers to the functional mitochondrial transcription factor A). There is no evidence for a protein product, biological function, or drug relevance for TFAMP2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor A, mitochondrial pseudogene 2 (TFAMP2).